Stem Cell-Derived Neurons for Neurodegenerative Disease Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for neurodegenerative diseases such as Parkinson's, Alzheimer's, and Huntington's lack effective solutions, as they primarily focus on symptom alleviation rather than addressing the progressive loss of neurons, and there is a need for a renewable source of replacement cells to restore neuronal function.

Innovation Solution

Administering neural stem cells (NSCs) or pluripotent stem cell-derived neurons or neuron precursor cells into the brain, which are partially or fully differentiated, to induce endogenous dopaminergic neurons to release dopamine, thereby increasing dopamine levels and treating neurodegenerative disorders.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current treatments for neurodegenerative diseases are used, then symptom alleviation is achieved, but the progressive loss of neurons continues and no durable cure is provided

Engineering Contradiction:
Improvedurability of treatmentVSAvoidprogressive loss of neurons
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The transplanted stem cells differentiate into dopaminergic neurons that autonomously produce and release dopamine within the patient's brain, creating a self-sustaining therapeutic effect that continuously counteracts neuronal loss without requiring external intervention

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention changes the fundamental parameter of neuronal population by introducing new dopamine-producing neurons through stem cell transplantation, transforming the disease state from progressive neuronal depletion to a state with restored neuronal function and dopamine production

Inventive Principle:
Principle #35Parameter changes

2Reliability

If stem cell therapy is used to replace lost neurons, then neuronal function is restored and dopamine levels increase, but the complexity of the treatment procedure increases

Engineering Contradiction:
Improverestoration of neuronal functionVSAvoidcomplexity of treatment procedure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Pluripotent stem cells are used as a universal source that can differentiate into multiple cell types including dopaminergic neurons, providing a single therapeutic approach that addresses the root cause of neurodegenerative diseases through cellular replacement rather than requiring disease-specific treatments

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

Stem cells serve as an intermediary vehicle that delivers the therapeutic effect by differentiating into functional dopaminergic neurons in situ, bridging the gap between external treatment administration and internal neuronal restoration without requiring direct manipulation of the patient's existing neurons

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If stem cells are administered to treat neurodegenerative diseases, then a renewable source of replacement cells is provided, but the difficulty of cell differentiation and administration increases

Engineering Contradiction:
Improverenewable source of replacement cellsVSAvoidease of cell differentiation and administration
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

Stem cells are differentiated into dopaminergic neuron precursors in vitro before administration, allowing optimization of cell maturation and quality control prior to transplantation, thereby simplifying the overall process by performing complex differentiation steps in a controlled laboratory environment rather than in the patient

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS11007232B2Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases
Publication Date: 2021.05.18 INT STEM CELL CORP
  • US11007232B2 patent drawing
  • US11007232B2 patent drawing
  • US11007232B2 patent drawing

AI summary

The present invention is based in part methods for treating neurodegenerative diseases and disorders. Specifically, the present invention disclose methods for treating neurodegenerative disorders suing neural stem cells (NSCs) and/or pluripotent stem cell (PSC) derived neurons or neuron precursor cells. The present invention also discloses methods to induce endogenous dopaminergic neurons to release dopamine and increase the levels of dopamine in a subject.